Pharmaceutical News

RSS

Triapine shows promise in treating breast cancer

Students at Tennessee Tech University are developing and testing a series of chemical compounds that show promise of stopping cancer in its tracks.

29 Oct 2012

Drug company to pay $95M to settle allegations of improper promotions for three drugs

Boehringer Ingelheim Pharmaceuticals Inc. will pay $95 million to settle allegations that the company promoted three drugs for uses that were not medically accepted, the government announced Thursday.

29 Oct 2012

New therapy to treat rare form of cystic fibrosis works in unconventional way, scientists say

Scientists at the Hospital for Sick Children in Toronto have established that a drug recently approved by the U.S. Food and Drug Administration to treat a rare form of cystic fibrosis works in an unconventional way.

29 Oct 2012

Neuraxial anesthesia should be promoted for bilateral total knee replacements: HSS

Using regional anesthesia rather than general anesthesia reduces the need for blood transfusions in patients undergoing bilateral total knee replacement, according to a new study by researchers at Hospital for Special Surgery, in New York City.

29 Oct 2012

New research report shows how bimatoprost causes human hair to regrow

If you're balding and want your hair to grow back, then here is some good news. A new research report appearing online in The FASEB Journal shows how the FDA-approved glaucoma drug, bimatoprost, causes human hair to regrow.

29 Oct 2012

Deutsche Welle examines emerging markets in developing countries for pharmaceutical industry

Deutsche Welle examines the widespread lack of access to medical supplies and drugs in developing countries and efforts by the pharmaceutical industry and others to bring new and lower-cost drugs into these emerging markets.

29 Oct 2012

Scientists identify mechanism via Top2b enzyme that drives doxorubicin-induced heart damage

Doxorubicin, a 50-year-old chemotherapy drug still in widespread use against a variety of cancers, has long been known to destroy heart tissue, as well as tumors, in some patients.

29 Oct 2012

Study demonstrates role of IRX4204 in alleviating cognitive decline in animal models of AD

New research presented in October at the 6th Neurodegenerative Conditions Research and Development Conference in San Francisco demonstrates the role of the investigational compound IRX4204 in alleviating cognitive decline in animal models of Alzheimer's disease (AD).

29 Oct 2012

Study identifies genetic variations as predictors of prostate cancer-related fatigue

Researchers at Moffitt Cancer Center and the University of South Florida have found that men with prostate cancer who receive androgen deprivation therapy may predictably suffer from fatigue if they have single nucleotide polymorphisms in three pro-inflammatory genes. The discovery highlights the importance of personalized medicine, in which therapies are tailored to a patient's genetic profile.

29 Oct 2012

Flu shot might also prevent heart disease

Getting a flu shot may not only protect you from getting sick, it might also prevent heart disease.

29 Oct 2012

Pfizer receives FDA approval for Synribo to treat chronic myelogenous leukemia

The U.S. Food and Drug Administration today approved Synribo (omacetaxine mepesuccinate) to treat adults with chronic myelogenous leukemia (CML), a blood and bone marrow disease.

29 Oct 2012

New anti-thrombotic treatments in AF patients can reduce risk of stroke

Atrial fibrillation, whose prevalence continues to rise, was described last year as the "new epidemic" in cardiovascular disease, even though AF can be successfully controlled by the detection and management of risk factors, by rhythm control treatments, and by the use of antithrombotic therapies.

29 Oct 2012

FDA approves Watson’s generic Actos

Watson Pharmaceuticals, Inc. today announced that Watson has launched a generic version of Actos (Pioglitazone Hydrochloride 15mg, 30mg and 45mg tablets) after receiving final approval today from the U.S. Food and Drug Administration (FDA).

29 Oct 2012

Contaminated drug passed lab test

Products from the Massachusetts pharmacy linked to the deadly meningitis outbreak passed a lab test in May, reports The Wall Street Journal. In addition, the pharmacy dodged a reprimand by Massachusetts regulators in 2004 after protesting it would be "fatal to the business." The company's founders come under scrutiny by media outlets as more people file lawsuits.

26 Oct 2012

New treatments show promise for people with food allergies

New treatments are offering the prospect of eating without fear for the 15 million people in the United States with food allergies, according to the cover story in the current issue of Chemical & Engineering News.

26 Oct 2012

Malawi needs donor support to maintain HIV/AIDS treatment program

In the last of a series of posts on the U.K. Department for International Development's (DfID) blog examining the department's work in Malawi, Neil Squires, DfID head of profession for health, looks at the sustainability of the country's HIV/AIDS program.

26 Oct 2012

Associated Press examines access to antiretroviral treatment in Myanmar

The Associated Press examines access to antiretroviral treatment in Myanmar, which "ranks among the world's hardest places to get HIV care, and health experts warn it will take years to prop up a broken health system hobbled by decades of neglect."

26 Oct 2012

Targeted deletion of major VEGF gene in mice induces vision loss

Millions of people with "wet" macular degeneration are prescribed a class of medication known as anti-VEGF drugs. But now scientists at The Scripps Research Institute (TSRI) have found that a drastic reduction of VEGF activity may do more harm than good.

26 Oct 2012

Differing opinions about AMFm 'unlikely to be resolved' after Global Fund decision on program's future

In her "Global Health Blog," Guardian health editor Sarah Boseley examines the Affordable Medicines Facility-malaria (AMFm), "which aims to enable countries to increase the provision of affordable artemisinin combination therapies (ACTs) through not only the public sector but also the private sector and [non-governmental organizations (NGOs)]."

26 Oct 2012

Researchers identify new means to eradicate malaria infections

Researchers have identified a new means to eradicate malaria infections by rapidly killing the blood-borne Plasmodium parasites that cause the disease.

26 Oct 2012

Pharmaceutical News

Triapine shows promise in treating breast cancer

Drug company to pay $95M to settle allegations of improper promotions for three drugs

New therapy to treat rare form of cystic fibrosis works in unconventional way, scientists say

Neuraxial anesthesia should be promoted for bilateral total knee replacements: HSS

New research report shows how bimatoprost causes human hair to regrow

Deutsche Welle examines emerging markets in developing countries for pharmaceutical industry

Scientists identify mechanism via Top2b enzyme that drives doxorubicin-induced heart damage

Study demonstrates role of IRX4204 in alleviating cognitive decline in animal models of AD

Study identifies genetic variations as predictors of prostate cancer-related fatigue

Flu shot might also prevent heart disease

Pfizer receives FDA approval for Synribo to treat chronic myelogenous leukemia

New anti-thrombotic treatments in AF patients can reduce risk of stroke

FDA approves Watson’s generic Actos

Contaminated drug passed lab test

New treatments show promise for people with food allergies

Malawi needs donor support to maintain HIV/AIDS treatment program

Associated Press examines access to antiretroviral treatment in Myanmar

Targeted deletion of major VEGF gene in mice induces vision loss

Differing opinions about AMFm 'unlikely to be resolved' after Global Fund decision on program's future

Researchers identify new means to eradicate malaria infections

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Latest News